Related Experiment Video

Updated: Aug 19, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Respiratory syncytial virus: old challenges and new approaches

Susana Chávez-Bueno1, Asunción Mejías, Hasan S Jafri

  • 1Pediatrics Department, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390-9063, USA.

Pediatric Annals
|February 8, 2005
PubMed

Insights

Better therapies and prevention strategies are needed to combat respiratory syncytial virus (RSV) disease globally. Improved measures may also reduce chronic consequences like recurrent wheezing in children following RSV lower respiratory tract infections (LRIs).

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Respiratory syncytial virus (RSV) poses a significant global health burden across all age groups.
  • Acute RSV disease can lead to severe lower respiratory tract infections (LRIs).

Purpose of the Study:

  • To highlight the need for improved therapies and prevention strategies for acute RSV disease.
  • To hypothesize the potential impact of these improved measures on chronic RSV sequelae in children.

Main Methods:

  • This study is a hypothesis-driven review and discussion.
  • It synthesizes existing knowledge on RSV pathogenesis and clinical outcomes.

Main Results:

  • Current therapies and prevention strategies for RSV are insufficient to meet global needs.
  • Improved interventions are hypothesized to reduce the incidence of chronic conditions.

Conclusions:

  • There is a critical need for enhanced global strategies to manage acute RSV infections.
  • Further research should investigate the long-term effects of RSV and the impact of novel interventions on chronic sequelae such as recurrent wheezing and pulmonary function abnormalities.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.